Skip to content

A Randomized Controlled Trial on Galactooligosaccharides Reshaping Intestinal Microbiota to Improve Airway Inflammation in Children with Nonspecific Chronic Cough

A Randomized Controlled Trial on Galactooligosaccharides Reshaping Intestinal Microbiota to Improve Airway Inflammation in Children with Nonspecific Chronic Cough

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088556
Enrollment
Unknown
Registered
2024-08-21
Start date
2023-09-01
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic cough

Interventions

Intervention group:Galactooligosaccharide oral dose 8g per day
Control group:Maltodextrin oral 8g per day

Sponsors

Shanghai Jingan District Zhabei Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 17 Years

Inclusion criteria

Inclusion criteria: 1. Children aged 4 to 17 years. 2. Persistent cough symptoms > 4 weeks. 3. Cough is the main or only complaint, and there is no obvious abnormality in chest X-ray. 4. Exclude chronic cough caused by other reasons such as congenital respiratory diseases, foreign body aspiration, bronchial asthma, bronchiectasis, etc. 5. Obtain written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with abdominal pain, bloating, diarrhea, vomiting or digestive system diseases. 2. Patients with nutrition and nutritional disorders, primary or secondary immunodeficiency diseases, autoimmune diseases, genetic metabolic diseases, and endocrine diseases.

Design outcomes

Primary

MeasureTime frame
FeNO;

Secondary

MeasureTime frame
Cough symptom score;Visual Analogue Scale;Leicester quality of life rating;Fecal microbial diversity analysis;Peripheral blood cell analysis;Peripheral blood CRP level;

Countries

China

Contacts

Public ContactLiu Danyang

Shanghai Jingan District Zhabei Central Hospital

cyan0118@163.com+86 131 2063 2505

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026